Kuili Fang

Postdoc Associate
Scaglione Lab
MSRBIII 3 Genome Ct.
Durham, NC 27710
Phone: 858-926-8483
Email: kuili.fang@duke.edu



Research Interest: Utilize biochemical and genetic techniques to investigate how disruptions in protein homeostasis of leading to Alzheimer’s disease by the model of Dictyostelium discoideum and use this knowledge to develop therapies.


Personal Interests:

Watch movies, watch basketball games, and eat delicious food


Publications List:

Fang, K., Park, O. J., & Hong, S. H. (2020). Controlling biofilms using synthetic biology approaches. Biotechnology Advances, 40, 107518.

Shao, X.*, Fang, K.*, Medina, D., Wan, J., Lee, J. L., & Hong, S. H. (2020). The probiotic, Leuconostoc mesenteroides, inhibits Listeria monocytogenes biofilm formation. Journal of Food Safety, 40(2), e12750.

*co-first author

Pimentel, M. B., Borges, F. T., Teymour, F., Zaborina, O. Y., Alverdy, J. C., Fang, K., … & Papavasiliou, G. (2020). An in vitro tissue model for screening sustained release of phosphate-based therapeutic attenuation of pathogen-induced proteolytic matrix degradation. Journal of Materials Chemistry B, 8(12), 2454-2465.

Wang, M., Fang, K., Hong, S. M. C., Kim, I., Jang, I. S., & Hong, S. H. (2018). Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB. Applied microbiology and biotechnology, 1-14.

Fang, K., Jin, X., & Hong, S. H. (2018). Probiotic Escherichia coli inhibits biofilm formation of pathogenic E. coli via extracellular activity of DegP. Scientific reports8(1), 4939.

Nam, D. H., Fang, K., Rodriguez, C., Lopez, T., & Ge, X. (2017). Generation of inhibitory monoclonal antibodies targeting matrix metalloproteinase-14 by motif grafting and CDR optimization. Protein Engineering, Design and Selection30(2), 113-118.